Overexpression of E2F mRNAs Associated with Gastric Cancer Progression Identified by the Transcription Factor and miRNA Co-Regulatory Network Analysis

Gene expression is regulated at the transcription and translation levels; thus, both transcription factors (TFs) and microRNAs (miRNA) play roles in regulation of gene expression. This study profiled differentially expressed mRNAs and miRNAs in gastric cancer tissues to construct a TF and miRNA co-regulatory network in order to identify altered genes in gastric cancer progression. A total of 70 cases gastric cancer and paired adjacent normal tissues were subjected to cDNA and miRNA microarray analyses. We obtained 887 up-regulated and 93 down-regulated genes and 41 down-regulated and 4 up-regulated miRNAs in gastric cancer tissues. Using the Transcriptional Regulatory Element Database, we obtained 105 genes that are regulated by the E2F family of genes and using Targetscan, miRanda, miRDB and miRWalk tools, we predicted potential targeting genes of these 45 miRNAs. We then built up the E2F-related TF and miRNA co-regulatory gene network and identified 9 hub-genes. Furthermore, we found that levels of E2F1, 2, 3, 4, 5, and 7 mRNAs associated with gastric cancer cell invasion capacity, and has associated with tumor differentiation. These data showed Overexpression of E2F mRNAs associated with gastric cancer progression.

[1]  Kai Li,et al.  MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. , 2010, Biochemical and biophysical research communications.

[2]  N. Rothman,et al.  Systemic cytokine levels and subsequent risk of gastric cancer in Chinese Women , 2011, Cancer science.

[3]  R. Rosell,et al.  mRNA expression of BRCA1, PIAS1, and PIAS4 and survival after second-line docetaxel in advanced gastric cancer. , 2011, Journal of the National Cancer Institute.

[4]  In-Sun Chu,et al.  Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Bin Liu,et al.  Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1 , 2010, Nature Genetics.

[6]  Tao Li,et al.  MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor , 2013, Oncogene.

[7]  R. Gershoni-baruch,et al.  Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers , 2014, British Journal of Cancer.

[8]  Zhengyan Kan,et al.  Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer , 2011, Nature Genetics.

[9]  C. C. Sage,et al.  Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis , 2013, Oncogene.

[10]  Fang Wang,et al.  MiR-19b/20a/92a regulates the self-renewal and proliferation of gastric cancer stem cells , 2013, Journal of Cell Science.

[11]  Wen Tan,et al.  A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1 , 2011, Nature Genetics.

[12]  Yueli Liu,et al.  Reduced miR-125a-5p expression is associated with gastric carcinogenesis through the targeting of E2F3. , 2014, Molecular medicine reports.

[13]  Hong Lu,et al.  Reduced microRNA‐218 expression is associated with high nuclear factor kappa B activation in gastric cancer , 2009, Cancer.

[14]  F. Greten.  YAP1 Takes Over when Oncogenic K-Ras Slumbers , 2014, Cell.

[15]  B. Xiao,et al.  Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance , 2010, Medical oncology.

[16]  D. Iliopoulos,et al.  E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. , 2008, Cancer cell.

[17]  Jian-Hong Wu,et al.  Effects of microRNA-106 on proliferation of gastric cancer cell through regulating p21 and E2F5. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[18]  G. Mills,et al.  ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer. , 2011, Cancer discovery.

[19]  Kazuhiro Yoshida,et al.  Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. , 2010, The Lancet. Oncology.

[20]  Jeffrey A. Thompson,et al.  Common features of microRNA target prediction tools , 2014, Front. Genet..

[21]  K. Nishio,et al.  Differential roles of STAT3 depending on the mechanism of STAT3 activation in gastric cancer cells , 2011, British Journal of Cancer.

[22]  A. Jemal,et al.  Global Patterns of Cancer Incidence and Mortality Rates and Trends , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[23]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[24]  S. Cho,et al.  Overexpression of miR‐17 in gastric cancer is correlated with proliferation‐associated oncogene amplification , 2014, Pathology international.

[25]  B. Pützer,et al.  Checks and balances: E2F—microRNA crosstalk in cancer control , 2010, Cell cycle.

[26]  X. Zou,et al.  Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells. , 2012, Cancer letters.

[27]  Ying Xu,et al.  QUBIC: a qualitative biclustering algorithm for analyses of gene expression data , 2009, Nucleic acids research.

[28]  Jianmin Si,et al.  MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2 , 2010, Cell Research.

[29]  Xia Li,et al.  Mir-509-5p joins the Mdm2/p53 feedback loop and regulates cancer cell growth , 2014, Cell Death and Disease.

[30]  J. Skotheim,et al.  Control of cell cycle transcription during G1 and S phases , 2013, Nature Reviews Molecular Cell Biology.

[31]  Bin Liu,et al.  : Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and , 2010 .

[32]  D. Thickett,et al.  Identification of novel vascular targets in lung cancer , 2014, British Journal of Cancer.

[33]  C. Croce,et al.  Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. , 2008, Cancer research.

[34]  Kou-Juey Wu,et al.  Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression. , 2012, Carcinogenesis.

[35]  Jihan Wang,et al.  Altered Expression of Hypoxia-Inducible Factor-1α (HIF-1α) and Its Regulatory Genes in Gastric Cancer Tissues , 2014, PloS one.

[36]  T. Halazonetis,et al.  Genomic instability — an evolving hallmark of cancer , 2010, Nature Reviews Molecular Cell Biology.

[37]  R. Stallings,et al.  Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. , 2007, Cancer research.

[38]  Yingyan Yu,et al.  miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. , 2010, Biochemical and biophysical research communications.

[39]  Norbert Gretz,et al.  miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes , 2011, J. Biomed. Informatics.

[40]  Wen-Chi Chou,et al.  An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer , 2010, Nucleic acids research.

[41]  Fred H. Gage,et al.  BRCA1 tumor suppression occurs via heterochromatin mediated silencing , 2011, Nature.

[42]  Xiaowei Wang.  miRDB: a microRNA target prediction and functional annotation database with a wiki interface. , 2008, RNA.

[43]  D. Cobrinik.  Pocket proteins and cell cycle control , 2005, Oncogene.

[44]  S. Lees-Miller,et al.  Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines , 2014, Cell cycle.

[45]  P. Altevogt,et al.  Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer , 2011, Oncogene.

[46]  R. Aguiar,et al.  MicroRNA-155 controls RB phosphorylation in normal and malignant B lymphocytes via the noncanonical TGF-β1/SMAD5 signaling module. , 2014, Blood.

[47]  Hanna Vauhkonen,et al.  Pathology and molecular biology of gastric cancer. , 2006, Best practice & research. Clinical gastroenterology.

[48]  D. Tan,et al.  Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. , 2009, Cancer research.

[49]  G. Semenza.  Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics , 2010, Oncogene.